TP53 and ovarian serous adenocarcinoma: Aside from the possibility of early precursor escape of TP53-mutant cells from TP53 foci commonly found in fallopian tubes (34–35), excess of TP53 clones observed in lavages from patients with serous ovarian cancer may correspond to endometrial TP53 field effects extending to the fallopian tube epithelium.